Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
作者:
主题词
肾上腺素能α激动剂(Adrenergic alpha-Agonists);肾上腺素能α拮抗剂(Adrenergic alpha-Antagonists);动物(Animals);抗震颤麻痹药(Antiparkinson Agents);苯丙氮|艹卓|类(Benzazepines);苯呋喃类(Benzofurans);可乐定(Clonidine);疾病模型, 动物(Disease Models, Animal);剂量效应关系, 药物(Dose-Response Relationship, Drug);肌电描记术(Electromyography);咪唑克生(Idazoxan);咪唑类(Imidazoles);咪唑啉受体(Imidazoline Receptors);注射, 腹腔内(Injections, Intraperitoneal);配体(Ligands);男(雄)性(Male);小鼠(Mice);肌僵硬(Muscle Rigidity);肌, 骨骼(Muscle, Skeletal);帕金森障碍(Parkinsonian Disorders);利血平(Reserpine);时间因素(Time Factors);育亨宾(Yohimbine)
DOI
10.1016/j.ejphar.2008.06.013
PMID
18602099
发布时间
2016-11-24
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文